Company: RGBP
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001641172-25-012619
Chunk: 0

Company: Regen BioPharma Inc
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
QUITY (DEFICIT)                                                                                                                                                                           
  Common Stock ($.0001 par value) 5,800,000,000 authorized and 21,554,704 and 5,258,235 shares issued and outstanding, respectively                            2,157                                  527  
  Preferred Stock, 0.0001 par value, 800,000,000 authorized                                                                                                        -                                    -  
  Series A Preferred; 739,000,000 authorized and 10,123,771 and 10,123,771 shares issued and outstanding, respectively                                         1,011                                1,011  
  Series AA Preferred; $ 0.0001 par value 600,000 authorized and 34 shares issued and outstanding                                                                  -                                    -  
  Series M Preferred; $ 0.0001 par value 60,000,000 authorized and 29,338 shares issued and outstanding                                                            3                                    3  
  Series NC Preferred; $ 0.0001 par value 20,000 authorized and 15,007 shares issued and outstanding                                                               2                                    2  
  Preferred Stock, Value                                                                                                                                           -                                    -  
  Additional Paid in capital                                                                                                                              15,455,134                           15,403,050  
  Other Comprehensive Income                                                                                                                               ( 204,847                            ( 204,847  
  Retained Earnings (Deficit)                                                                                                                           ( 20,951,859                         ( 20,417,118  
  Total Stockholders’ Equity (Deficit)                                                                                                                   ( 5,698,399                          ( 5,217,372  
  TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)                                                                                     $                   169,482      $                       161,084  

The
Accompanying Notes are an Integral Part of These Financial Statements

All
stock amounts have been retroactively adjusted to reflect a 1 for 1500 reverse stock split

   2  

REGEN
BIOPHARMA, INC.

CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

                                                                                                                                  2025           2024                         2025      2024                 
                                                                                                 Period Ended March 31                                                                                       
                                                                                                 3 Months                                                  6 Months                                          
                                                                                                 2025                                                      2025                         2024                 
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────